Estonia - Esti - Ravimiamet

sia elvim - topiramaat - õhukese polümeerikattega tablett - 50mg 60tk; 50mg 28tk

Estonia - Esti - Ravimiamet

orion corporation - topiramaat - õhukese polümeerikattega tablett - 50mg 60tk; 50mg 100tk

Estonia - Esti - Ravimiamet

sandoz pharmaceuticals d.d. - topiramaat - õhukese polümeerikattega tablett - 50mg 6tk; 50mg 20tk; 50mg 60tk; 50mg 28tk; 50mg 5tk; 50mg 10tk; 50mg 100tk

Estonia - Esti - Ravimiamet

orion corporation - topiramaat - õhukese polümeerikattega tablett - 100mg 60tk; 100mg 100tk

Estonia - Esti - Ravimiamet

sia elvim - topiramaat - õhukese polümeerikattega tablett - 100mg 28tk

Estonia - Esti - Ravimiamet

orion corporation - topiramaat - õhukese polümeerikattega tablett - 200mg 100tk; 200mg 60tk

Uni Eropa - Esti - EMA (European Medicines Agency)

mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Uni Eropa - Esti - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Uni Eropa - Esti - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Uni Eropa - Esti - EMA (European Medicines Agency)

teva gmbh - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).